You are here

Symposium Overview: Present Clinical Drug Trial Programs for the Treatment of Lymphoma

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
The author reviews vaccine studies, combination rituximab trials, and developments with antisense therapy, proteosome inhibitors, and promising monoclonal antibodies.